Orthocell gives mobility back to quadriplegic patients
Orthocell's (ASX: OCC) regenerative device, CelGro, is helping give mobility back to quadriplegic patients.
Orthocell's (ASX: OCC) regenerative device, CelGro, is helping give mobility back to quadriplegic patients.
Orthocell Limited (ASX: OCC) is a world-leading regenerative medicine company providing innovative products to restore mobility, function and performance.
This week we were joined by the CEOs of exciting ASX listed businesses, who gave valuable insight to their industries...